Neil Stahl Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity
Neil Stahl is EVP Research and Development of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 49,599 shares of REGN, which is worth approximately $57.2 Million. The most recent transaction as insider was on Dec 03, 2021, when has been sold 50,352 shares (Common Stock) at a price of $632.45 per share, resulting in proceeds of $31,845,123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
49.6K
2.75%
3M change
6.59%
12M change
Total Value Held
$57.2 Million
NEIL STAHL Transaction History
NS
Neil Stahl
EVP Research and Development
Tarrytown, NY